Countries trying to shift to clean energy while also preparing for extreme weather and other impacts in a warmer world will ...

The IMF paper by Nils H. Lehr and Pascual Restrepo argues that socially responsible AI firms should price their technologies ...

Q3 2025 Management View CEO Joseph Payne reported that interim Phase II data for ARCT-032, the company’s mRNA therapeutic candidate for cystic fibrosis (CF), showed "treatment with inhaled ...

We're here to help you win more at fantasy football — and have fun doing it. Award-winning analyst Scott Pianowski will deliver actionable advice to entertain, inform and assist in drafting, lineup ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease ...